ILIKF Stock Chart & Stats
$0.51
-$0.02(-6.96%)
At close: 4:00 PM EST
$0.51
-$0.02(-6.96%)
Day’s Range― - ―
52-Week Range$0.30 - $0.69
Previous CloseN/A
Volume9.66K
Average Volume (3M)110.77K
Market Cap
$76.16M
Enterprise Value$50.60M
Total Cash (Recent Filing)$6.92M
Total Debt (Recent Filing)$562.20K
Price to Earnings (P/E)―
Beta0.81
Next Earnings
Jul 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding198,889,310
10 Day Avg. Volume77,793
30 Day Avg. Volume110,768
Financial Highlights & Ratios
PEG Ratio-0.42
Price to Book (P/B)3.31
Price to Sales (P/S)773.54
P/FCF Ratio-9.05
Enterprise Value/Market Cap0.66
Enterprise Value/Revenue9.55K
Enterprise Value/Gross Profit-21.12
Enterprise Value/Ebitda-7.47
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)$27.21K
Bulls Say, Bears Say
Bulls Say
Commercialized Stereax DeliveriesQualified manufacturing at Cirtec and M300 deliveries to customers provide durable commercial validation. A partner-run production route reduces scale-up risk, initial cathode purchase orders create a recurring revenue path (cathode/NRE/royalty streams) and shorten the time to repeatable product sales.
Goliath Prototyping And Scale-upValidated 2 Ah then 10 Ah prototypes plus an automated pilot line demonstrate technical feasibility and manufacturability at larger format. This materially de-risks licensing to OEMs/Tier‑1s and supports a structural path to scale manufacturing and future recurring licensing/profit‑share revenue streams.
IP Base & Asset-light Licensing ModelA 78-patent portfolio and an asset-light licensing model create durable competitive advantages: lower capital needs, multiple monetization channels (NRE, cathode deposition, royalties) and higher barriers to entry. Structurally this conserves capital and scales revenue without heavy factory capex.
Bears Say
Steep Revenue Decline & LossesA ~96% revenue collapse and persistently negative margins signal the business is not yet generating sustainable product revenue. Over months this undermines the firm's ability to self-fund commercialization, increases financing/dilution risk and constrains reinvestment into scale and customer support.
Negative Operating Cash Flow & Shrinking CashNegative operating/free cash flow and a ~31% cash decline at H1 create a structural runway constraint. Reliance on grants and R&D tax credits for near-term funding leaves the company exposed to funding timing, potentially forcing dilution, delaying commercialization investments or slowing customer rollouts.
Long Licensing Timelines & Execution RisksA multi‑year (~30 months) timeline for Goliath licensing, plus pending external validation, means material revenue is uncertain and distant. Combined with competitive and technical trade-offs, this lengthens the conversion horizon, raising structural execution risk and pressuring capital requirements before licensing cash flows arrive.
Ilika plc News
ILIKF FAQ
What was Ilika PLC’s price range in the past 12 months?
Ilika PLC lowest stock price was $0.30 and its highest was $0.69 in the past 12 months.
What is Ilika PLC’s market cap?
Ilika PLC’s market cap is $76.16M.
When is Ilika PLC’s upcoming earnings report date?
Ilika PLC’s upcoming earnings report date is Jul 29, 2026 which is in 4 days.
How were Ilika PLC’s earnings last quarter?
Ilika PLC released its earnings results on Jan 22, 2026. The company reported -$0.027 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Ilika PLC overvalued?
According to Wall Street analysts Ilika PLC’s price is currently Overvalued.
Does Ilika PLC pay dividends?
Ilika PLC does not currently pay dividends.
What is Ilika PLC’s EPS estimate?
Ilika PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ilika PLC have?
Ilika PLC has 198,889,310 shares outstanding.
What happened to Ilika PLC’s price movement after its last earnings report?
Ilika PLC reported an EPS of -$0.027 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.006%.
Which hedge fund is a major shareholder of Ilika PLC?
Currently, no hedge funds are holding shares in ILIKF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ilika plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ILIKF Sentiment 100%
Sector Average 63%
Sector Average 63%
Insider Transactions
Bought Shares
Worth $26.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
89.58%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-14.79%
Trailing 12-Months
Company Description
Ilika PLC
Ilika plc, an enterprise established in 2004 with its headquarters in Romsey, United Kingdom, focuses on the conception, refinement, and commercial production of solid-state battery technology. These advanced power cells are distributed globally under their Stereax brand, primarily serving markets in the UK, Asia, mainland Europe, and North America. The company's battery solutions find application across numerous sectors, such as industrial Internet of Things, medical apparatus, various transportation systems including electric vehicles, and portable consumer electronics, as well as supporting smart city initiatives.
Technical Analysis
Ownership Overview
0.55% Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.45% Public Companies and
Individual Investors